Timing of ADT in Radiotherapy of Prostate Cancer

被引：1
|
作者：
Hoecht, Stefan [1 ]
Mason, Malcom [2 ]
Wiegel, Thomas [3 ]
机构：
[1] Xcare Grp Practices, Dept Radiotherapy, Saarlouis, Germany
[2] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, Wales
[3] Ulm Univ Hosp, Dept Radiotherapy, Ulm, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 20期
关键词：
ANDROGEN-DEPRIVATION;
D O I：
10.1200/JCO.21.00032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2315 / +
页数：2
相关论文
共 50 条
  • [41] Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer
    Kishan, Amar U.
    Tendulkar, Rahul D.
    Tran, Phuoc T.
    Parkers, Christopher C.
    Nguyen, Paul L.
    Stephenson, Andrew J.
    Carrie, Christian
    EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (01): : 3 - 18
  • [42] Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?
    Hasan, Shaakir
    Gorovets, Daniel
    Lehrer, Eric J.
    Lazarev, Stanislav
    Press, Robert H.
    Garg, Madhur
    Mehta, Keyur J.
    Chhabra, Arpit M.
    Choi, J. Isabelle
    Simone, Charles B., II
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 26 : 47 - 54
  • [43] Preliminary Results of a Randomized Trial of Optimal Timing of Dose Escalated (76 Gy) Radiation and 6 months ADT in Prostate Cancer
    Malone, S.
    Eapen, L.
    Kendal, W.
    MacRae, R.
    D'Amico, A.
    Perry, G.
    Bowen, J.
    Malone, K.
    Grimes, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S362 - S362
  • [44] The urologist is a key determinant of ADT use in men with prostate cancer
    Nature Clinical Practice Urology, 2006, 3 (9): : 461 - 461
  • [45] HORMONAL THERAPIES ADT for prostate cancer: true love or heartbreak?
    Efstathiou, Jason A.
    Shipley, William U.
    Zietman, Anthony L.
    Smith, Matthew R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (03) : 130 - 132
  • [46] Prostate cancer: ADT-who, when and for how long?
    Farley S.J.
    Nature Reviews Urology, 2009, 6 (8) : 403 - 403
  • [47] PATCH-ing up toxicities of ADT for prostate cancer
    Wilson, H.
    Abel, P.
    Shah, I.
    ANNALS OF ONCOLOGY, 2015, 26 : 75 - 75
  • [48] Androgen deprivation therapy (ADT) for node postive prostate cancer
    Wong, Y.
    Freedland, S.
    Hudes, G.
    Mitra, N.
    Montagnet, C.
    Armstrong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] TARGETING METABOLIC DYSFUNCTION INDUCED BY ADT IN ADVANCE PROSTATE CANCER
    Gunter, Jennifer
    Ree, Handoo
    Sarkar, Phoebe
    Lee, Wendy
    Philp, Lisa
    Hollier, Brett
    Williams, Elizabeth
    Vela, Ian
    Sadowski, Martin
    Lehman, Melanie
    Nelson, Colleen C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 30 - 30
  • [50] Salvage prostate bed radiotherapy: co-irradiation of regional LNs and significance of ADT
    Grabenbauer, Felix
    Flentje, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (12) : 1119 - 1121
12345